Agios Pharmaceuticals Inc (NASDAQ:AGIO)

88.03
Delayed Data
As of Apr 18
 +1.17 / +1.35%
Today’s Change
45.11
Today|||52-Week Range
89.33
+53.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues65.4M59.1M69.9M43.0M
 
 
 
 
 
Depreciation And Amortization1.4M3.3M5.7M6.4M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses118.1M174.5M265.2M357.4M
 
 
 
 
 
Research And Development100.4M141.8M220.2M292.7M
 
 
 
 
 
Total Operating Expenses119.5M177.8M270.9M363.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-54.1M-118.7M-201.0M-320.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-53.9M-117.7M-198.5M-314.7M
 
 
 
 
 
Income Taxes-426.0K0.000.000.00
 
 
Net Income-53.5M-117.7M-198.5M-314.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.7M37.4M39.1M46.6M
 
 
 
 
 
Shares To Calculate EPS Diluted33.7M37.4M39.1M46.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.59-$3.15-$5.07-$6.75
 
 
 
 
 
EPS Diluted-$1.59-$3.15-$5.07-$6.75